GLP-1 drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by around half. Meanwhile, tech companies are ...

Sleep apnea is a common sleep disorder that affects more than 20 percent of people in the United States. It happens when your ...

Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known ...

As a sleep medicine specialist, Dr. Christopher J. Allen knows well the importance of sleep health, which is not only defined ...

Research hints that medications like Zepbound and Wegovy could provide new ways to treat opioid and alcohol abuse.

A mong the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for ...

As we start looking to the year ahead, the pharma industry is gearing up for a slate of new drug launches and U.S. Food and ...

If you have obstructive sleep apnea (OSA)—a condition that causes a partial or complete collapse of your upper airway while sleeping—you’re likely familiar with continuous positive airway pressure ...

Weight-loss drugs such as Ozempic, made by Denmark’s Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, ...

Left untreated, obstructive sleep apnea is linked to daytime sleepiness and an increased risk of anxiety, diabetes, ...

The drugs have been approved in the U.S. and Europe to treat diabetes or obesity ... which the company markets for weight loss, reduced the severity of sleep apnea by up to nearly two-thirds ...

Weight-loss drugs like Wegovy and Zepbound are transforming the health of millions of people—and a new study hints that even more could benefit from the drugs’ other effects on the body.